Delivery Order SPE2DE21D7020-SPE2D626F12PY
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,094.40 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of December 17, 2025. This fixed-price contract with economic price adjustment was awarded on December 10, 2025, and is issued without a small business set-aside. The delivery order is placed against Boston Scientific's single-award Blanket Purchase Agreement with the Defense...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a $1,476.55 fixed-price delivery order (Contract No. 4570394377) by the Defense Health Agency's Medical Supply Chain on January 5, 2026, with an ultimate completion date of January 12, 2026. This delivery order is issued against Boston Scientific's single-award Blanket Purchase Agreement valued at $750,000 with a ceiling through March 30, 2030, which designates the company as the sole supplier of radiation treatment...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division, effective October 24, 2025, with an ultimate completion date of October 31, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's existing single-award...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,475.10 by the Defense Health Agency's Medical Supply Chain division under a fixed-price contract with economic price adjustment provisions. The award, issued on January 5, 2026, with an ultimate completion date of January 12, 2026, represents a continuation of Boston Scientific's role as a critical supplier of specialized medical devices to federal healthcare entities. This...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on December 5, 2025, with an ultimate completion date of December 12, 2025, is designated as a fixed-price delivery order with economic price adjustment provisions. This award is issued without small business set-aside restrictions, allowing Boston Scientific to compete on an unrestricted...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $16,425.00 by the Defense Health Agency's Medical Supply Chain division on January 12, 2026, with an ultimate completion date of January 20, 2026. The contract utilizes fixed-price pricing with economic price adjustment and was awarded without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. This delivery order is issued against Boston...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $19,920.74 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of November 18, 2025. This delivery order, issued on November 10, 2025, is a non-set-aside award issued without small business restrictions. The contract utilizes fixed-price pricing with economic price adjustment terms and represents a task order issued against Boston...
- Boston Scientific Corp has been awarded a delivery order valued at $1,024.00 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of January 23, 2026. This fixed-price contract with economic price adjustment was issued on January 15, 2026, and will be performed at the company's headquarters in Marlborough, Massachusetts. The delivery order was awarded without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. This...
- Boston Scientific Corp has been awarded a delivery order valued at $7,705.80 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of December 19, 2025. The contract, issued December 12, 2025, is a fixed-price delivery order with economic price adjustment provisions and carries no small business set-aside. This award is issued against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency, a single-award indefinite delivery...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,997.14 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of January 13, 2026. This fixed-price contract with economic price adjustment provisions was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The delivery order is issued against a larger single-award Blanket Purchase...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F12PYDelivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $7,737.20 by the Defense Health Agency's Medical Supply Chain division. The contract, issued on January 16, 2026, with an ultimate completion date of January 26, 2026, operates under a fixed-price arrangement with economic price adjustment provisions. This delivery order is issued against Boston Scientific's existing single-award Blanket Purchase Agreement with the Defense Health Agency, which carries a $750,000 ceiling and runs through March 30, 2030. The BPA, designated specifically for radiation treatment devices, establishes Boston Scientific as the sole supplier for these specialized oncology solutions to federal healthcare entities. No small business set-aside was applied to this award. The delivery order supports the Defense Health Agency's requirement for radiation treatment technologies, including yttrium-90 glass microspheres and related radiopharmaceutical products essential for cancer treatment across military healthcare facilities and Veterans Affairs medical centers. This contract represents the federal government's continued reliance on Boston Scientific's specialized capabilities in delivering complex medical devices while maintaining critical supply chain continuity for advanced oncology treatments across the defense and veterans healthcare enterprises. The short performance timeline reflects the urgent nature of resupply requirements for these life-critical medical interventions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 1/15/26 |